Provider
The company will use the funds to hasten product development, engineering and go-to-market efforts to meet market demand.
Connor Glass, founder and CEO of Phantom Neuro, discusses the company's muscle-machine interface that allows individuals with limb loss to control robotic limbs and systems using electrical activity from their own muscles.
Connor Glass, founder and CEO of Phantom Neuro, explains how the company's muscle-machine interface for amputees is enabling the development of advanced prosthetic limbs designed to function as natural extensions of the human body.
HIMSS25
Essex County College's Elvy Vieira says the college is increasing access to health technology jobs by offering a data science degree and credentialing courses, as well as a dual enrollment program for high schoolers.
The company will use the funds to invest in research and development and to scale its voice AI platform.
Employees will have access to clinical content and more than 900 U.S. clinics that specialize in fertility, urology and menopause.
The company will use the funds to advance its AI-enabled robotic platform for cataract and other eye surgeries, with plans to begin human clinical trials this year.
The Series E funding comes four months after the company secured $250 million in a Series D round.
HIMSS25
AI tools can personalize patients' searches for providers, but Kyruus Health's Gen Conlin believes nurse informaticists' ability to ensure tool accessibility and accuracy are vital to ensuring patients find the right care.
Selected early versions will be slated for real-world deployment.